EUCTR2006-000267-29-IT进行中（未招募）不适用
Adjuvant chemotherapy in stage III colon carcinoma in patients age or 70 years. Feasibility of CAPOX scheme oxaliplatin 70 mg/mq days 1-8 and capecitabine 1000 mg/mq X 2 die days 1-14 every 21 days for 6 cycles - ND
Centro sociale oncologico0 个研究点目标入组 15 人开始时间: 2006年4月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Radically operated Stage III colon carcinoma . Age or 70 years. PS 0 or 1. Absence of preexisting peripheral neuropathy. Adequate liver and kidney functionality.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Metastatic colon carcinoma . PS 1. Creatinin clearance 30 . Blood bilirubin 1,5 times the normal level. Neuropaty of any degree and origin.
研究者
相似试验
已完成
3 期
Randomized phase III study of adjuvant chemotherapy with combination therapy of gemcitabine and S-1 vs. gemcitabine alone in patients with resected pancreatic cancer (JSAP-04)Resected pancreatic cancerJPRN-UMIN000004410Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP)300
招募中
不适用
Phase III Randomized Trial of Adjuvant Chemotherapy with TS-1 vs TS-1/oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II TrialKCT0003993Samsung Medical Center900
进行中（未招募）
1 期
Study of chemotherapy vs immunotherapy for patients with lung cancer bounded inthe thorax and completely resectedResectable Non-small cell lung cancerMedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104MedDRA version: 20.0Level: SOCClassification code: 10029104Term: Neoplasms benign malignant and unspecified (incl cysts and polyps) Class: 2CTIS2024-513730-38-00Fundacion GECP210
已完成
3 期
Phase III Randomized Adjuvant Study of Chemotherapy in Node Positive Breast Cancer Patients -AC(Anthracycline-Cyclophosphamide) 4 cycles followed by Taxane 4 cycles (AC-Tac) versus Taxane 8 cycles and Paclitaxel versus DocetaxelJPRN-C000000055-SAS BC 02 executive committee1,200
尚未招募
不适用
Validation of adjuvant chemotherapy for colorectal cancer in patients with renal dysfunctiocolon cancerJPRN-UMIN000047045Japanese Foundation for Multidisciplinary Treatment of Cancer4,327